CN102351800A - Method for preparing 5-methylbenzimidazole-2-methyl carbamate - Google Patents
Method for preparing 5-methylbenzimidazole-2-methyl carbamate Download PDFInfo
- Publication number
- CN102351800A CN102351800A CN2011102673464A CN201110267346A CN102351800A CN 102351800 A CN102351800 A CN 102351800A CN 2011102673464 A CN2011102673464 A CN 2011102673464A CN 201110267346 A CN201110267346 A CN 201110267346A CN 102351800 A CN102351800 A CN 102351800A
- Authority
- CN
- China
- Prior art keywords
- methyl
- reaction
- methylbenzimidazole
- cyanamide
- cyanocarbamate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 17
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 51
- 238000006243 chemical reaction Methods 0.000 claims abstract description 51
- ZSYJMXLJNPEAGP-UHFFFAOYSA-N methyl n-cyanocarbamate Chemical compound COC(=O)NC#N ZSYJMXLJNPEAGP-UHFFFAOYSA-N 0.000 claims abstract description 39
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 claims abstract description 36
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 claims abstract description 25
- BCHKNFQUOAQOET-UHFFFAOYSA-N methyl n-(6-methyl-1h-benzimidazol-2-yl)carbamate Chemical compound C1=C(C)C=C2NC(NC(=O)OC)=NC2=C1 BCHKNFQUOAQOET-UHFFFAOYSA-N 0.000 claims abstract description 17
- 230000020477 pH reduction Effects 0.000 claims abstract description 17
- 238000002360 preparation method Methods 0.000 claims abstract description 17
- 238000007363 ring formation reaction Methods 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 8
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 claims abstract description 8
- 235000019345 sodium thiosulphate Nutrition 0.000 claims abstract description 8
- -1 Sodium oxide cyanamide Chemical compound 0.000 claims abstract description 4
- 238000006482 condensation reaction Methods 0.000 claims abstract description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 52
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 35
- 239000000243 solution Substances 0.000 claims description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 239000002904 solvent Substances 0.000 claims description 22
- 238000003756 stirring Methods 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 18
- DGRGLKZMKWPMOH-UHFFFAOYSA-N 4-methylbenzene-1,2-diamine Chemical compound CC1=CC=C(N)C(N)=C1 DGRGLKZMKWPMOH-UHFFFAOYSA-N 0.000 claims description 14
- 239000003444 phase transfer catalyst Substances 0.000 claims description 12
- 239000013078 crystal Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000003054 catalyst Substances 0.000 claims description 10
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 8
- 239000007864 aqueous solution Substances 0.000 claims description 8
- KXHPPCXNWTUNSB-UHFFFAOYSA-M benzyl(trimethyl)azanium;chloride Chemical group [Cl-].C[N+](C)(C)CC1=CC=CC=C1 KXHPPCXNWTUNSB-UHFFFAOYSA-M 0.000 claims description 7
- 239000012065 filter cake Substances 0.000 claims description 7
- 239000005457 ice water Substances 0.000 claims description 7
- 230000007935 neutral effect Effects 0.000 claims description 7
- 239000012074 organic phase Substances 0.000 claims description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 238000000967 suction filtration Methods 0.000 claims description 6
- 239000002585 base Substances 0.000 claims description 5
- 239000008098 formaldehyde solution Substances 0.000 claims description 5
- 238000004508 fractional distillation Methods 0.000 claims description 5
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 claims description 5
- 229910000041 hydrogen chloride Inorganic materials 0.000 claims description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims description 4
- HTZCNXWZYVXIMZ-UHFFFAOYSA-M benzyl(triethyl)azanium;chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC1=CC=CC=C1 HTZCNXWZYVXIMZ-UHFFFAOYSA-M 0.000 claims description 4
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 claims description 4
- 239000000047 product Substances 0.000 claims description 4
- TWFZGCMQGLPBSX-UHFFFAOYSA-N carbendazim Chemical compound C1=CC=C2NC(NC(=O)OC)=NC2=C1 TWFZGCMQGLPBSX-UHFFFAOYSA-N 0.000 claims description 3
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 239000002244 precipitate Substances 0.000 claims description 2
- 239000012266 salt solution Substances 0.000 claims description 2
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- CWJJAFQCTXFSTA-UHFFFAOYSA-L 4-methylphthalate Chemical compound CC1=CC=C(C([O-])=O)C(C([O-])=O)=C1 CWJJAFQCTXFSTA-UHFFFAOYSA-L 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims 1
- 238000003828 vacuum filtration Methods 0.000 claims 1
- 239000002699 waste material Substances 0.000 abstract description 4
- 239000002253 acid Substances 0.000 abstract description 3
- 239000003344 environmental pollutant Substances 0.000 abstract description 3
- 231100000719 pollutant Toxicity 0.000 abstract description 3
- CWJJAFQCTXFSTA-UHFFFAOYSA-N 4-methylphthalic acid Chemical compound CC1=CC=C(C(O)=O)C(C(O)=O)=C1 CWJJAFQCTXFSTA-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 150000004985 diamines Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- YCQZDRXPYGNHMP-UHFFFAOYSA-N [Na].COC(=O)NC#N Chemical compound [Na].COC(=O)NC#N YCQZDRXPYGNHMP-UHFFFAOYSA-N 0.000 description 4
- UVJYATLICUROFI-UHFFFAOYSA-M sodium;n-cyano-n-methylcarbamate Chemical compound [Na+].N#CN(C)C([O-])=O UVJYATLICUROFI-UHFFFAOYSA-M 0.000 description 4
- 239000008139 complexing agent Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 230000000855 fungicidal effect Effects 0.000 description 3
- 239000000417 fungicide Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 238000006798 ring closing metathesis reaction Methods 0.000 description 3
- DUHMOOFLRYKWKX-UHFFFAOYSA-N (6-methyl-1h-benzimidazol-2-yl)carbamic acid Chemical compound CC1=CC=C2N=C(NC(O)=O)NC2=C1 DUHMOOFLRYKWKX-UHFFFAOYSA-N 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000006013 carbendazim Substances 0.000 description 2
- JNPZQRQPIHJYNM-UHFFFAOYSA-N carbendazim Chemical compound C1=C[CH]C2=NC(NC(=O)OC)=NC2=C1 JNPZQRQPIHJYNM-UHFFFAOYSA-N 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000010985 leather Substances 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- GTCAXTIRRLKXRU-UHFFFAOYSA-N methyl carbamate Chemical compound COC(N)=O GTCAXTIRRLKXRU-UHFFFAOYSA-N 0.000 description 2
- RZXMPPFPUUCRFN-UHFFFAOYSA-N p-toluidine Chemical compound CC1=CC=C(N)C=C1 RZXMPPFPUUCRFN-UHFFFAOYSA-N 0.000 description 2
- 239000005060 rubber Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 239000004753 textile Substances 0.000 description 2
- 238000005292 vacuum distillation Methods 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 1
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002888 effect on disease Effects 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- IUEBEACSGQRJBB-UHFFFAOYSA-N methyl n-(1h-imidazol-2-yl)carbamate Chemical compound COC(=O)NC1=NC=CN1 IUEBEACSGQRJBB-UHFFFAOYSA-N 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000001119 stannous chloride Substances 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种5-甲基苯并咪唑-2-氨基甲酸甲酯的制备方法,将反应步骤控制为氰胺化、酸化、合环三步,简化了操作程序,采用强碱如氢氧化钠氰胺化,盐酸酸化,硫代硫酸钠催化合环,减少了废酸的产生,在保证产品质量和收率的前提下,减少了污染物的生成量。本发明的步骤如下:以氯甲酸甲酯为原料,经过氰胺化反应、酸化反应和合环反应后得到产品;其中,所述的氰胺化反应为氯甲酸甲酯碱性条件下与氰胺反应生成氰氨基甲酸甲酯盐;所述的酸化反应为氰氨基甲酸甲酯盐与盐酸反应生成氰氨基甲酸甲酯;所述的合环反应为氰氨基甲酸甲酯与4-甲基邻苯二胺在酸催化条件下发生缩合反应,得到5-甲基苯并咪唑-2-氨基甲酸甲酯。
The invention discloses a preparation method of methyl 5-methylbenzimidazole-2-carbamate. The reaction steps are controlled into three steps of cyanamide, acidification and ring closing, the operation procedure is simplified, and a strong base such as hydrogen is used. Sodium oxide cyanamide, hydrochloric acid acidification, sodium thiosulfate catalyzed ring closing, reduce the generation of waste acid, and reduce the generation of pollutants under the premise of ensuring product quality and yield. The steps of the present invention are as follows: using methyl chloroformate as a raw material, the product is obtained after cyanamide reaction, acidification reaction and ring closure reaction; wherein, the cyanamide reaction is methyl chloroformate and cyanamide under alkaline conditions The reaction generates methyl cyanocarbamate; the acidification reaction is that methyl cyanocarbamate reacts with hydrochloric acid to generate methyl cyanocarbamate; the ring closure reaction is methyl cyanocarbamate and 4-methyl o-phthalate The diamine undergoes condensation reaction under acid-catalyzed conditions to obtain methyl 5-methylbenzimidazole-2-carbamate.
Description
技术领域 technical field
本发明涉及一种杀菌剂的制备方法,更具体地说涉及一种5-甲基苯并咪唑-2-氨基甲酸甲酯即5-甲基多菌灵的制备方法。The present invention relates to a kind of preparation method of bactericide, more specifically relate to a kind of preparation method of 5-methylbenzimidazole-2-carbamate methyl ester namely 5-methylcarbendazim.
背景技术 Background technique
5-甲基苯并咪唑-2-氨基甲酸甲酯即5-甲基多菌灵,属于高效、广谱、低毒的内吸杀菌剂,化学性质稳定,毒性低,急性毒性半数致死剂量即LD50值:对大白鼠经口大于20g/kg(优于多菌灵的LD50值,为15g/kg)。属于高效广谱类杀菌剂,可被植物吸收并经传导转移到其它部位,干扰病菌细胞的有丝分裂,抑制其生长。对多种作物由真菌(如半知菌、多子囊菌等)引起的病害有防治效果,可用于叶面喷雾、种子处理和土壤处理等。还可广泛用于木材、造纸、纺织、皮革、橡胶等工业的防霉杀菌领域。目前国内没有相关的文献报道其合成方法。5-Methylbenzimidazole-2-carbamate, namely 5-methylcarbendazim, is a highly efficient, broad-spectrum, and low-toxic systemic fungicide with stable chemical properties and low toxicity. The half-lethal dose of acute toxicity is LD50 value: oral administration to rats is greater than 20g/kg (better than the LD50 value of carbendazim, which is 15g/kg). It belongs to the high-efficiency broad-spectrum fungicide, which can be absorbed by plants and transferred to other parts through conduction, interfering with the mitosis of germ cells and inhibiting their growth. It has the control effect on diseases caused by fungi (such as Deuteromycetes, polyascomycetes, etc.) of various crops, and can be used for foliar spraying, seed treatment and soil treatment, etc. It can also be widely used in the fields of anti-mildew and sterilization in wood, papermaking, textile, leather, rubber and other industries. At present, there is no related literature reporting its synthesis method in China.
目前仅Ernest Lacey等(Biochemical Pharmacology,Vol.34,No.7,pp.1073-1077,1985)报道了以对甲基苯胺为原料经乙酰化、硝化、水解、还原、成环、重排等步骤制备5-甲基苯并咪唑-2-氨基甲酸甲酯,其中反应步骤过长,所用的试剂如氯化亚锡、溴化氰、异硫脲等毒性较大,且不易工业化生产。At present, only Ernest Lacey et al. (Biochemical Pharmacology, Vol.34, No.7, pp.1073-1077, 1985) have reported the use of p-methylaniline as raw material through acetylation, nitration, hydrolysis, reduction, ring formation, rearrangement, etc. The step is to prepare methyl 5-methylbenzimidazole-2-carbamate, wherein the reaction steps are too long, and the reagents used, such as stannous chloride, cyanogen bromide, isothiourea, etc., are highly toxic and difficult for industrial production.
发明内容 Contents of the invention
本发明的目的是解决现在技术中存在的问题与不足,提供一种5-甲基苯并咪唑-2-氨基甲酸甲酯的制备方法,本发明的方法将反应步骤控制为氰胺化、酸化、合环三步,简化了操作程序,采用强碱如氢氧化钠氰胺化,盐酸酸化,硫代硫酸钠催化合环,减少了废酸的产生,在保证产品质量和收率的前提下,减少了污染物的生成量。The purpose of the present invention is to solve the problems and deficiencies existing in the prior art, and provide a kind of preparation method of 5-methylbenzimidazole-2-carbamate methyl ester, the method of the present invention controls reaction step as cyanamide,
本发明的技术方案如下:Technical scheme of the present invention is as follows:
本发明的5-甲基苯并咪唑-2-氨基甲酸甲酯的制备方法,步骤如下:以氯甲酸甲酯为原料,经过氰胺化反应、酸化反应和合环反应后得到5-甲基苯并咪唑-2-氨基甲酸甲酯;其中,The preparation method of 5-methylbenzimidazole-2-methyl carbamate of the present invention, the steps are as follows: take methyl chloroformate as raw material, obtain 5-methylbenzene after cyanamide reaction, acidification reaction and ring closure reaction Methyl imidazole-2-carbamate; where,
所述的氰胺化反应为氯甲酸甲酯碱性条件下与氰胺反应生成氰氨基甲酸甲酯盐;The cyanamide reaction is that methyl chloroformate reacts with cyanamide under alkaline conditions to generate methyl cyanocarbamate;
所述的酸化反应为氰氨基甲酸甲酯盐与盐酸反应生成氰氨基甲酸甲酯;The acidification reaction is that methyl cyanocarbamate salt reacts with hydrochloric acid to generate methyl cyanocarbamate;
所述的合环反应为氰氨基甲酸甲酯与4-甲基邻苯二胺在酸催化条件下发生缩合反应,得到5-甲基苯并咪唑-2-氨基甲酸甲酯。The ring-closing reaction is a condensation reaction between methyl cyanocarbamate and 4-methyl-o-phenylenediamine under acid-catalyzed conditions to obtain methyl 5-methylbenzimidazole-2-carbamate.
本发明的5-甲基苯并咪唑-2-氨基甲酸甲酯的制备方法,其进一步的技术方案是所述的氰胺化反应步骤如下:先配制氰胺水溶液,并加入溶剂,再用5mol/L-10mol/L强碱水溶液调节pH值大于9,再加入相转移催化剂,升温搅拌,滴加氯甲酸甲酯发生氰胺化反应,反应结束后,将产物倒入冰水混合物中,析出固体,真空抽滤,滤饼依次用甲醇洗和水洗至中性,干燥可得氰氨基甲酸甲酯的盐晶体。再进一步的技术方案是所述的氰胺化反应步骤如下:在-10℃-70℃搅拌条件下,先后将10%-80%质量浓度的氰胺水溶液、溶剂、5mol/L-10mol/L强碱水溶液、相转移催化剂投入反应釜中,控制溶液pH值大于9,再以10g/h-100g/h的速率均匀滴加氯甲酸甲酯,反应1h-8h后,得到氰氨基甲酸甲酯盐溶液,倒入冰水混合物中,析出晶体,760mmHg真空条件下抽滤,滤饼依次用甲醇洗和水洗至中性,干燥可得氰氨基甲酸甲酯的盐晶体;其中,氯甲酸甲酯、氰胺溶液中的单氰胺、强碱的摩尔比为1.0∶1.0-2.0∶2.0-5.0。The preparation method of 5-methylbenzimidazole-2-methyl carbamate of the present invention, its further technical scheme is that described cyanamide reaction step is as follows: first prepare cyanamide aqueous solution, and add solvent, then use 5mol /L-10mol/L strong alkali aqueous solution to adjust the pH value to be greater than 9, then add a phase transfer catalyst, heat up and stir, add methyl chloroformate dropwise to undergo cyanamide reaction, after the reaction, pour the product into the ice-water mixture, and precipitate The solid is vacuum filtered, and the filter cake is washed with methanol and water in turn until neutral, and dried to obtain the salt crystal of methyl cyanocarbamate. A further technical solution is that the described cyanamide reaction steps are as follows: under the stirring condition of -10°C-70°C, successively mix 10%-80% mass concentration of cyanamide aqueous solution, solvent, 5mol/L-10mol/L Put the strong alkali aqueous solution and phase transfer catalyst into the reaction kettle, control the pH value of the solution to be greater than 9, and then uniformly drop methyl chloroformate at a rate of 10g/h-100g/h, and react for 1h-8h to obtain methyl cyanocarbamate Pour the salt solution into the ice-water mixture to precipitate crystals, suction filter under 760mmHg vacuum condition, wash the filter cake with methanol and water in turn until neutral, and dry to obtain the salt crystals of methyl cyanocarbamate; among them,
本发明的5-甲基苯并咪唑-2-氨基甲酸甲酯的制备方法,其再进一步的技术方案还可以是所述的强碱优选为氢氧化钠或氢氧化钾;所述的溶剂优选为水、甲醇、乙醇、丙酮中的一种或它们的混合物,溶剂的用量为氯甲酸甲酯质量用量的1-10倍;所述的相转移催化剂优选为苄基三甲基氯化铵、苄基三乙基氯化铵、聚乙二醇、十二烷基苯磺酸钠中的一种或它们的混合物,相转移催化剂用量为氯甲酸甲酯质量用量的0.1%-10%。The preparation method of 5-methylbenzimidazole-2-methyl carbamate of the present invention, its further technical scheme can also be that described strong base is preferably sodium hydroxide or potassium hydroxide; Described solvent is preferably It is one of water, methanol, ethanol, acetone or their mixture, and the consumption of solvent is 1-10 times of the mass consumption of methyl chloroformate; Described phase transfer catalyst is preferably benzyltrimethylammonium chloride, One of benzyltriethylammonium chloride, polyethylene glycol, sodium dodecylbenzene sulfonate or their mixture, the amount of phase transfer catalyst is 0.1%-10% of the mass amount of methyl chloroformate.
本发明的5-甲基苯并咪唑-2-氨基甲酸甲酯的制备方法,其进一步的技术方案还可以是所述的酸化反应步骤如下:将氰胺化反应得到的氰氨基甲酸甲酯的盐晶体,用4mol/L-5mol/L盐酸水解酸化,用己醇萃取,收集有机相,减压蒸馏,分馏得到氰氨基甲酸甲酯。更进一步的技术方案是所述的酸化反应步骤如下:在20℃-70℃搅拌条件下,将氰氨基甲酸甲酯盐与4mol/L-5mol/L盐酸充分混合反应,其中氯甲酸甲酯盐与盐酸溶液中的氯化氢的摩尔比为1.0∶1.0-2.0,控制溶液的pH值在6-7之间,反应1h-3h后,用己醇萃取,收集有机相,减压蒸馏,分馏得到氰氨基甲酸甲酯。The preparation method of 5-methylbenzimidazole-2-methyl carbamate of the present invention, its further technical scheme can also be that described acidification reaction step is as follows: the methyl cyanocarbamate that cyanamide reaction obtains Salt crystals were hydrolyzed and acidified with 4mol/L-5mol/L hydrochloric acid, extracted with ethanol, the organic phase was collected, distilled under reduced pressure, and fractionated to obtain methyl cyanocarbamate. A further technical solution is that the acidification reaction steps are as follows: Under the condition of stirring at 20°C-70°C, fully mix and react methyl cyanocarbamate salt with 4mol/L-5mol/L hydrochloric acid, wherein methyl chloroformate The molar ratio of hydrogen chloride to hydrochloric acid solution is 1.0:1.0-2.0, and the pH value of the solution is controlled between 6-7. After reacting for 1h-3h, extract with ethanol, collect the organic phase, distill under reduced pressure, and obtain cyanide by fractional distillation. Methyl carbamate.
本发明的5-甲基苯并咪唑-2-氨基甲酸甲酯的制备方法,其进一步的技术方案还可以是所述的合环反应步骤如下:取4-甲基邻苯二胺为原料,溶于适量溶剂中,加入酸化反应得到的氰氨基甲酸甲酯和催化剂,均匀滴加35%浓盐酸溶液,滴加终点为pH值在3-4,反应结束后热抽滤,再用35%甲醛在70℃-80℃下搅拌0.5h-1h,抽滤,干燥,即得5-甲基苯并咪唑-2-氨基甲酸甲酯。再进一步的技术方案是所述的合环反应步骤如下:在20℃-100℃搅拌条件下,先后将纯度为99%的4-甲基邻苯二胺、氰氨基甲酸甲酯、溶剂、催化剂投入反应釜中,再以10g/h-100g/h的速率均匀滴加35%浓盐酸,滴加温度30℃-100℃,控制溶液的pH值在3-4,反应2h-3h后热抽滤,再用35%甲醛溶液在70℃-80℃下搅拌0.5h-1h,离心,抽滤,干燥,可得5-甲基苯并咪唑-2-氨基甲酸甲酯;其中4-甲基邻苯二胺与氰氨基甲酸甲酯的摩尔比为1.0∶1.0-2.0。The preparation method of 5-methylbenzimidazole-2-methyl carbamate of the present invention, its further technical scheme can also be that described ring closing reaction step is as follows: take 4-methyl o-phenylenediamine as raw material, Dissolve in an appropriate amount of solvent, add methyl cyanocarbamate and catalyst obtained from the acidification reaction, and evenly add 35% concentrated hydrochloric acid solution dropwise. Stir formaldehyde at 70°C-80°C for 0.5h-1h, filter with suction, and dry to obtain methyl 5-methylbenzimidazole-2-carbamate. A further technical solution is that the steps of the ring-closing reaction are as follows: under the stirring condition of 20°C-100°C, 4-methyl o-phenylenediamine with a purity of 99%, methyl cyanocarbamate, solvent, and catalyst Put it into the reaction kettle, then evenly add 35% concentrated hydrochloric acid dropwise at a rate of 10g/h-100g/h, drop the temperature at 30°C-100°C, control the pH value of the solution at 3-4, and heat it after 2h-3h Filter, then stir with 35% formaldehyde solution at 70°C-80°C for 0.5h-1h, centrifuge, filter with suction, and dry to obtain methyl 5-methylbenzimidazole-2-carbamate; where 4-methyl The molar ratio of o-phenylenediamine to methyl cyanocarbamate is 1.0:1.0-2.0.
本发明的5-甲基苯并咪唑-2-氨基甲酸甲酯的制备方法,其更进一步的技术方案还可以是所述的溶剂优选为水、氯仿、己醇、甲醇、乙醇中的一种或它们的混合物,溶剂用量为氯甲酸甲酯质量用量的1-10倍。所述的催化剂优选为硫代硫酸钠,其用量为4-甲基邻苯二胺的0.1%-10%。The preparation method of 5-methylbenzimidazole-2-methyl carbamate of the present invention, its further technical scheme can also be that described solvent is preferably a kind of in water, chloroform, hexanol, methanol, ethanol Or their mixture, the solvent consumption is 1-10 times of the mass consumption of methyl chloroformate. The catalyst is preferably sodium thiosulfate in an amount of 0.1%-10% of 4-methyl o-phenylenediamine.
本发明的上述过程涉及的反应方程式如下:The reaction equation that above-mentioned process of the present invention relates to is as follows:
①氰胺化工序:氯甲酸甲酯与氰胺、氢氧化钠反应生成氰氨基甲酸甲酯钠盐。①Cyanamide process: methyl chloroformate reacts with cyanamide and sodium hydroxide to form sodium methyl cyanocarbamate.
②酸化工序:氰氨基甲酸甲酯钠盐与盐酸反应生成氰氨基甲酸甲酯。②Acidification process: methyl cyanocarbamate sodium salt reacts with hydrochloric acid to generate methyl cyanocarbamate.
③合环工序:氰氨基甲酸甲酯与4-甲基邻苯二胺在酸催化条件下发生缩合反应,生成5-甲基苯并咪唑-2-氨基甲酸甲酯。③ Ring closing process: methyl cyanocarbamate and 4-methyl o-phenylenediamine undergo condensation reaction under acid-catalyzed conditions to generate methyl 5-methylbenzimidazole-2-carbamate.
与现有技术相比,本发明的的有益效果主要体现在以下几方面:Compared with the prior art, the beneficial effects of the present invention are mainly reflected in the following aspects:
1、该工艺采用廉价易得的氯甲酸甲酯和4-甲基邻苯二胺为原料,将反应过程控制为氰胺化、酸化、合环三步,简化了操作程序,降低了生产成本。1. The process uses cheap and easy-to-obtain methyl chloroformate and 4-methyl-o-phenylenediamine as raw materials, and controls the reaction process into three steps of cyanamide, acidification, and ring closure, which simplifies the operation procedure and reduces the production cost .
2、该工艺采用苄基三甲基氯化铵作为氰胺化反应的相转移催化剂,反应条件温和,催化效果佳,继而减少氢氧化钠的用量,使废碱液量降低。2. The process adopts benzyltrimethylammonium chloride as the phase transfer catalyst of cyanamide reaction, the reaction conditions are mild, the catalytic effect is good, and then the amount of sodium hydroxide is reduced to reduce the amount of waste lye.
3、该工艺采用价廉的硫代硫酸钠作为合环反应的催化剂,反应条件温和,催化剂用量低,并且具有高转化率、绿色清洁的特点,进而可减少浓盐酸的用量,使废酸量降低,大大降低污染物的排放量,对环境友好,具有良好的经济效益和社会效益。3. The process uses cheap sodium thiosulfate as the catalyst for the ring-closing reaction. The reaction conditions are mild, the amount of catalyst is low, and it has the characteristics of high conversion rate, green and clean, which can reduce the amount of concentrated hydrochloric acid and make the amount of waste acid Reduce, greatly reduce the discharge of pollutants, friendly to the environment, and have good economic and social benefits.
4、产物5-甲基苯并咪唑-2-氨基甲酸甲酯与多菌灵的杀菌效果相当,属于高效、低毒、广谱、内吸杀菌剂,持效期长,毒性较多菌灵更低,可广泛用于农作物、木材、造纸、纺织、皮革、橡胶等工业的防霉杀菌领域。4. The product 5-methylbenzimidazole-2-carbamate has the same bactericidal effect as carbendazim. It is a high-efficiency, low-toxicity, broad-spectrum, systemic fungicide with long duration and more toxicity. Lower, can be widely used in crops, wood, paper, textiles, leather, rubber and other industries in the field of mildew and sterilization.
本发明与现有合成路线相比,具有反应路线简便、反应条件温和、催化活性高、原料廉价易得、工艺简单清洁的优点。Compared with the existing synthetic route, the present invention has the advantages of simple and convenient reaction route, mild reaction conditions, high catalytic activity, cheap and easy-to-obtain raw materials, and simple and clean process.
附图说明 Description of drawings
图1为实施例1制得的5-甲基苯并咪唑-2-氨基甲酸甲酯的MS图Fig. 1 is the MS figure of the 5-methylbenzimidazole-2-methyl carbamate that
图2为实施例1制得的5-甲基苯并咪唑-2-氨基甲酸甲酯的1H-NMR图。Fig. 2 is the 1 H-NMR chart of methyl 5-methylbenzimidazole-2-carbamate prepared in Example 1.
具体实施方式 Detailed ways
以下通过具体实施例说明本发明,但本发明并不仅仅限定于这些实施例。The present invention is illustrated below through specific examples, but the present invention is not limited to these examples.
实施例1Example 1
在250mL带有温度计及搅拌装置的四口烧瓶中,加入16.8g 50%氰胺溶液(含单氰胺0.2mol)、60ml甲醇溶剂、64g浓度25%的NaOH溶液(含NaOH 0.4mol)及0.5g苄基三甲基氯化铵作相转移催化剂,以30g/h的速率均匀滴加氯甲酸甲酯18.9g(0.2mol),保持45℃反应约3h后将反应液冷却,然后将其倒入大量的冰水混合物中,有白色晶体析出,在760mmHg真空条件下抽滤,滤饼依次用甲醇洗和水洗至中性,干燥可得氰氨基甲酸甲酯钠盐18.7g,收率为76.8%。In a 250mL four-necked flask with a thermometer and a stirring device, add 16.8g of 50% cyanamide solution (containing 0.2mol of cyanamide), 60ml of methanol solvent, 64g of 25% NaOH solution (containing 0.4mol of NaOH) and 0.5 g benzyltrimethylammonium chloride was used as a phase transfer catalyst, and 18.9 g (0.2 mol) of methyl chloroformate was uniformly added dropwise at a rate of 30 g/h, kept at 45 ° C for about 3 hours, and the reaction solution was cooled, and then poured into a large amount of ice-water mixture, white crystals are precipitated, suction filtration under 760mmHg vacuum condition, the filter cake is washed with methanol and washed to neutrality successively, and dried to obtain 18.7g of methyl cyanocarbamate sodium salt, the yield is 76.8 %.
在250mL带有温度计及搅拌装置的四口烧瓶中,将制得的18.3g(0.15mol)氰氨基甲酸甲酯钠盐与5mol/L盐酸30ml(含氯化氢0.15mol)在40℃混合反应2.5h后,用己醇萃取,收集有机相,减压蒸馏,分馏得到氰氨基甲酸甲酯13.5g,收率为90.3%。In a 250mL four-necked flask equipped with a thermometer and a stirring device, mix and react 18.3g (0.15mol) of sodium methyl cyanocarbamate and 30ml of 5mol/L hydrochloric acid (containing 0.15mol of hydrogen chloride) at 40°C for 2.5h Afterwards, extract with ethanol, collect the organic phase, vacuum distillation, and fractional distillation to obtain 13.5 g of methyl cyanocarbamate, and the yield is 90.3%.
在250mL带有温度计及搅拌装置的四口烧瓶中,加入12.3g(0.2mol)纯度为99%的4-甲基邻苯二胺、40ml甲醇溶剂、10g(0.1mol)氰氨基甲酸甲酯及0.8g硫代硫酸钠催化剂,以30g/h的速率均匀滴加35%浓盐酸溶液,滴加温度50℃,滴加终点为pH值在3-4左右,在90℃下进行保温反应2h,保温反应后需降温到80℃,加入络合剂35%甲醛溶液100ml,保温1h,最后再离心,水洗至中性,抽滤,干燥可得5-甲基苯并咪唑-2-氨基甲酸甲酯15.0g,收率为73.2%,熔点:330℃-335℃。MS(m/z):206[M+1]+。1H-NMR(300Hz,DMSO-d6),δ:2.36(s,3H,5-CH3),3.74(s,3H,CH3),6.89(m,1H,6-H),7.19(d,J=0.63,1H,4-H),7.26(d,J=8.04,1H,7-H),11.56(s,2H,NH,用D20可替换)。In a 250mL four-necked flask with a thermometer and a stirring device, add 12.3g (0.2mol) of 99% 4-methyl o-phenylenediamine, 40ml of methanol solvent, 10g (0.1mol) of methyl cyanocarbamate and 0.8g of sodium thiosulfate catalyst, uniformly drip 35% concentrated hydrochloric acid solution at a rate of 30g/h, the temperature of the addition is 50°C, the end point of the addition is when the pH value is around 3-4, and the reaction is carried out at 90°C for 2 hours. After the heat preservation reaction, cool down to 80°C, add 100ml of complexing agent 35% formaldehyde solution, keep warm for 1 hour, centrifuge again, wash with water until neutral, filter with suction, and dry to obtain methyl 5-methylbenzimidazole-2-carbamate 15.0 g of ester, yield 73.2%, melting point: 330°C-335°C. MS (m/z): 206 [M+1] + . 1 H-NMR (300Hz, DMSO-d6), δ: 2.36(s, 3H, 5-CH 3 ), 3.74(s, 3H, CH 3 ), 6.89(m, 1H, 6-H), 7.19(d , J=0.63, 1H, 4-H), 7.26 (d, J=8.04, 1H, 7-H), 11.56 (s, 2H, NH, replaceable with D20 ).
实施例2Example 2
在250mL带有温度计及搅拌装置的四口烧瓶中,加入33.6g 50%氰胺溶液(含单氰胺0.4mol)、60ml甲醇溶剂、64g浓度25%的NaOH溶液(含NaOH 0.4mol)及0.5g苄基三甲基氯化铵作相转移催化剂,以30g/h的速率均匀滴加氯甲酸甲酯18.9g(0.2mol),保持45℃反应约3h后将反应液冷却,然后将其倒入大量的冰水混合物中,有白色晶体析出,在760mmHg真空条件下抽滤,滤饼依次用甲醇洗和水洗至中性,干燥可得氰氨基甲酸甲酯钠盐21.0g,收率为86.0%。In a 250mL four-necked flask with a thermometer and a stirring device, add 33.6g of 50% cyanamide solution (containing 0.4mol of cyanamide), 60ml of methanol solvent, 64g of 25% NaOH solution (containing 0.4mol of NaOH) and 0.5 g benzyltrimethylammonium chloride was used as a phase transfer catalyst, and 18.9 g (0.2 mol) of methyl chloroformate was uniformly added dropwise at a rate of 30 g/h, kept at 45 ° C for about 3 hours, and the reaction solution was cooled, and then poured into a large amount of ice-water mixture, white crystals are precipitated, suction filtration under 760mmHg vacuum condition, the filter cake is washed with methanol and washed to neutrality successively, and dried to obtain 21.0g of methyl cyanocarbamate sodium salt, the yield is 86.0 %.
在250mL带有温度计及搅拌装置的四口烧瓶中,将制得的18.8g(0.15mol)氰氨基甲酸甲酯钠盐与5mol/L盐酸60ml(含氯化氢0.3mol)在40℃混合反应2.5h后,用己醇萃取,收集有机相,减压蒸馏,分馏得到氰氨基甲酸甲酯13.8g,收率为92.3%。In a 250mL four-neck flask equipped with a thermometer and a stirring device, mix and react 18.8g (0.15mol) of sodium methyl cyanocarbamate and 60ml of 5mol/L hydrochloric acid (containing 0.3mol of hydrogen chloride) at 40°C for 2.5h Afterwards, extract with ethanol, collect the organic phase, vacuum distillation, fractional distillation to obtain 13.8 g of methyl cyanocarbamate, the yield is 92.3%.
在250mL带有温度计及搅拌装置的四口烧瓶中,加入12.3g(0.1mol)纯度为99%的4-甲基邻苯二胺、40ml甲醇溶剂、15g(0.15mol)氰氨基甲酸甲酯及0.8g硫代硫酸钠催化剂,以30g/h的速率均匀滴加35%浓盐酸溶液,滴加温度50℃,滴加终点为pH值在3-4左右,在90℃下进行保温反应2h,保温反应后需降温到80℃,加入络合剂35%甲醛溶液100ml,保温1h,最后再离心,水洗至中性,抽滤,干燥可得5-甲基苯并咪唑-2-氨基甲酸甲酯16.3g,收率为79.5%,熔点:330℃-335℃。In a 250mL four-necked flask with a thermometer and a stirring device, add 12.3g (0.1mol) of 99% 4-methyl o-phenylenediamine, 40ml of methanol solvent, 15g (0.15mol) of methyl cyanocarbamate and 0.8g of sodium thiosulfate catalyst, uniformly drip 35% concentrated hydrochloric acid solution at a rate of 30g/h, the dropping temperature is 50°C, the end point of the addition is when the pH value is around 3-4, and the temperature is kept at 90°C for 2h. After the heat preservation reaction, cool down to 80°C, add 100ml of complexing agent 35% formaldehyde solution, keep warm for 1 hour, centrifuge again, wash with water until neutral, filter with suction, and dry to obtain methyl 5-methylbenzimidazole-2-carbamate 16.3 g of ester, yield 79.5%, melting point: 330°C-335°C.
实施例3Example 3
在250mL带有温度计及搅拌装置的四口烧瓶中,加入33.6g 50%氰胺溶液(含单氰胺0.4mol)、60ml甲醇溶剂、96g浓度25%的NaOH溶液(含NaOH 0.6mol)及0.5g苄基三甲基氯化铵作相转移催化剂,以30g/h的速率均匀滴加氯甲酸甲酯18.9g(0.2mol),保持45℃反应约3h后将反应液冷却,然后将其倒入大量的冰水混合物中,有白色晶体析出,在760mmHg真空条件下抽滤,滤饼依次用甲醇洗和水洗至中性,干燥可得氰氨基甲酸甲酯钠盐20.1g,收率为82.2%。In a 250mL four-necked flask with a thermometer and a stirring device, add 33.6g of 50% cyanamide solution (containing 0.4mol of cyanamide), 60ml of methanol solvent, 96g of 25% NaOH solution (containing 0.6mol of NaOH) and 0.5 g benzyltrimethylammonium chloride was used as a phase transfer catalyst, and 18.9 g (0.2 mol) of methyl chloroformate was uniformly added dropwise at a rate of 30 g/h, kept at 45 ° C for about 3 hours, and the reaction solution was cooled, and then poured into a large amount of ice-water mixture, white crystals are precipitated, suction filtration under 760mmHg vacuum condition, the filter cake is washed with methanol and washed to neutrality successively, and dried to obtain 20.1g of methyl cyanocarbamate sodium salt, the yield is 82.2 %.
在250mL带有温度计及搅拌装置的四口烧瓶中,将制得的18.3g(0.15mol)氰氨基甲酸甲酯钠盐与5mol/L盐酸50ml(含氯化氢0.25mol)在40℃混合反应2.5h后,用己醇萃取,收集有机相,减压蒸馏,分馏得到氰氨基甲酸甲酯13.6g,收率为90.3%。In a 250mL four-necked flask equipped with a thermometer and a stirring device, mix and react 18.3g (0.15mol) of sodium methyl cyanocarbamate and 50ml of 5mol/L hydrochloric acid (containing 0.25mol of hydrogen chloride) at 40°C for 2.5h After that, extract with ethanol, collect the organic phase, distill under reduced pressure, obtain 13.6 g of methyl cyanocarbamate by fractional distillation, and the yield is 90.3%.
在250mL带有温度计及搅拌装置的四口烧瓶中,加入12.3g(0.1mol)纯度为99%的4-甲基邻苯二胺、40ml甲醇溶剂、20g(0.2mol)氰氨基甲酸甲酯及0.8g硫代硫酸钠催化剂,以30g/h的速率均匀滴加35%浓盐酸溶液,滴加温度50℃,滴加终点为pH值在3-4左右,在90℃下进行保温反应2h,保温反应后需降温到80℃,加入络合剂35%甲醛溶液100ml,保温1h,最后再离心,水洗至中性,抽滤,干燥可得5-甲基苯并咪唑-2-氨基甲酸甲酯15.8g,收率为76.8%,熔点:330℃-335℃。In a 250mL four-necked flask with a thermometer and a stirring device, add 12.3g (0.1mol) of 99% 4-methyl o-phenylenediamine, 40ml of methanol solvent, 20g (0.2mol) of methyl cyanocarbamate and 0.8g of sodium thiosulfate catalyst, uniformly drip 35% concentrated hydrochloric acid solution at a rate of 30g/h, the dropping temperature is 50°C, the end point of the addition is when the pH value is around 3-4, and the temperature is kept at 90°C for 2h. After the heat preservation reaction, cool down to 80°C, add 100ml of complexing agent 35% formaldehyde solution, keep warm for 1 hour, centrifuge again, wash with water until neutral, filter with suction, and dry to obtain methyl 5-methylbenzimidazole-2-carbamate 15.8 g of ester, yield 76.8%, melting point: 330°C-335°C.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011102673464A CN102351800A (en) | 2011-09-09 | 2011-09-09 | Method for preparing 5-methylbenzimidazole-2-methyl carbamate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011102673464A CN102351800A (en) | 2011-09-09 | 2011-09-09 | Method for preparing 5-methylbenzimidazole-2-methyl carbamate |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102351800A true CN102351800A (en) | 2012-02-15 |
Family
ID=45575470
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011102673464A Pending CN102351800A (en) | 2011-09-09 | 2011-09-09 | Method for preparing 5-methylbenzimidazole-2-methyl carbamate |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102351800A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103058932A (en) * | 2013-02-01 | 2013-04-24 | 黄河三角洲京博化工研究院有限公司 | Synthetic method of N-(2-benzimidazolyl)-methyl carbamate |
CN104961655A (en) * | 2015-06-11 | 2015-10-07 | 安徽东至广信农化有限公司 | Process for hydrolyzing lime nitrogen at one step |
CN104961685A (en) * | 2015-06-11 | 2015-10-07 | 安徽东至广信农化有限公司 | Method for reducing carbendazim impurity DAP in production process of carbendazim |
CN111423442A (en) * | 2020-04-03 | 2020-07-17 | 重庆美莱德生物医药有限公司 | Epinastine hydrochloride intermediate and synthesis method thereof |
CN111574460A (en) * | 2020-07-06 | 2020-08-25 | 山东国邦药业有限公司 | Preparation method of albendazole |
CN116396227A (en) * | 2023-03-21 | 2023-07-07 | 江苏省人民医院(南京医科大学第一附属医院) | 2-amino substituted bendamustine derivative with HDAC (high-voltage analog to digital converter) inhibition effect, and preparation method and application thereof |
CN116730872A (en) * | 2023-06-14 | 2023-09-12 | 安徽东至广信农化有限公司 | Process for synthesizing methyl cyanamide |
-
2011
- 2011-09-09 CN CN2011102673464A patent/CN102351800A/en active Pending
Non-Patent Citations (2)
Title |
---|
ERNEST LACEY ET AL.: "Structure-activity relationships of benzimidazole carbamates an inhibitors of mammalian tubulin, in vitro", 《BIOCHEMICAL PHARMACOLOGY》 * |
庄海燕: "多菌灵的合成研究", 《中国优秀硕士学位论文全文数据库工程科技I辑》 * |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103058932A (en) * | 2013-02-01 | 2013-04-24 | 黄河三角洲京博化工研究院有限公司 | Synthetic method of N-(2-benzimidazolyl)-methyl carbamate |
CN103058932B (en) * | 2013-02-01 | 2015-10-07 | 京博农化科技股份有限公司 | The synthetic method of N-(2-benzimidazolyl-)-Urethylane |
CN104961655A (en) * | 2015-06-11 | 2015-10-07 | 安徽东至广信农化有限公司 | Process for hydrolyzing lime nitrogen at one step |
CN104961685A (en) * | 2015-06-11 | 2015-10-07 | 安徽东至广信农化有限公司 | Method for reducing carbendazim impurity DAP in production process of carbendazim |
CN104961655B (en) * | 2015-06-11 | 2017-01-18 | 安徽东至广信农化有限公司 | Process for hydrolyzing lime nitrogen at one step |
CN115504985A (en) * | 2020-04-03 | 2022-12-23 | 重庆美莱德生物医药有限公司 | Synthesis method of epinastine hydrochloride |
CN111423442B (en) * | 2020-04-03 | 2022-09-27 | 重庆美莱德生物医药有限公司 | Epinastine hydrochloride intermediate and synthesis method thereof |
CN111423442A (en) * | 2020-04-03 | 2020-07-17 | 重庆美莱德生物医药有限公司 | Epinastine hydrochloride intermediate and synthesis method thereof |
CN115504985B (en) * | 2020-04-03 | 2024-01-19 | 重庆美莱德生物医药有限公司 | Synthesis method of epinastine hydrochloride |
CN111574460A (en) * | 2020-07-06 | 2020-08-25 | 山东国邦药业有限公司 | Preparation method of albendazole |
CN111574460B (en) * | 2020-07-06 | 2021-11-05 | 山东国邦药业有限公司 | Preparation method of albendazole |
CN116396227A (en) * | 2023-03-21 | 2023-07-07 | 江苏省人民医院(南京医科大学第一附属医院) | 2-amino substituted bendamustine derivative with HDAC (high-voltage analog to digital converter) inhibition effect, and preparation method and application thereof |
CN116730872A (en) * | 2023-06-14 | 2023-09-12 | 安徽东至广信农化有限公司 | Process for synthesizing methyl cyanamide |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102351800A (en) | Method for preparing 5-methylbenzimidazole-2-methyl carbamate | |
EP2215050B1 (en) | Manufacturing method of 2-hydroxy-5-phenylalkylaminobenzoic acid derivatives and their salts | |
TWI685488B (en) | Method for preparing intermediate of Azotomin (Azoxystyrin) | |
CN102977011A (en) | Process for preparing pyridinamines and novel polymorphs thereof | |
CN102816122A (en) | Preparation method of pyrimethanil | |
CN101367746B (en) | Novel method for synthesizing -metolachlor | |
CN108863909A (en) | A kind of novel halogen amine structure compound and preparation method thereof and the application of antibacterial field | |
CN103588682B (en) | Preparation method of 1, 3-diamino guanidine hydrochloride | |
CN102702104B (en) | Method for continuously synthesizing 3-difluoromethyl-1-methylpyrazole-4-ethyl formate | |
CN102838514B (en) | The synthetic method of cyclohexasulfame | |
CN108623488B (en) | A kind of synthetic method of aminotoluic acid | |
CN101391969B (en) | Method for preparing N-methyl-2-(2,4-dichlorophenoxy) acetamide | |
CN102229531B (en) | Preparation method of p-hydroxy benzal propane diacid derivative | |
CN105601523B (en) | A kind of method for synthesizing the chloroaniline of 2,5 dimethoxy 4 | |
CN104649947B (en) | A kind of preparation method of 2,2 '-dibenzamido diphenyl disulfide zinc salt | |
CN105254611B (en) | The preparation method of the carboxylic acid of benzothiophene 2 | |
CN106957226B (en) | A kind of preparation method of prohexadione calcium | |
CN107245060B (en) | Synthesis method of 3-acetyl-4-nitroimino-1, 3, 5-oxadiazine | |
CN105294697B (en) | The synthetic method of 2- amino -5,8- dimethoxy [1,2,4] triazol [1,5-c] pyrimidine | |
CN115385903A (en) | A kind of preparation method of cyano-substituted benzoxazin-4-one derivative | |
CN101607914A (en) | Simple method for preparing to tert-butyl benzyl amine | |
CN101575301A (en) | Preparation method of 2-amino-5-chlorobenzamide | |
CN114685300A (en) | Preparation method of o-chlorophenylglycine | |
CN103910695B (en) | A kind of synthetic method of Febuxostat | |
CN106008391B (en) | A kind of preparation method of -3 (2H) -one of 2- phenyl -1,1- dioxy -1,2- benzisothiazoles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120215 |